Novocure Adds Monthly Stipend for CMO Role

By Chris Stiles • Friday, April 10 10:50 • Permanent Link

Novocure GmbH has added a monthly stipend of CHF 5,000 to compensate Uri Weinberg for taking on the role of chief medical officer while continuing as chief innovation officer.

The new payment is tied to the additional assignment and will be paid for the duration of that assignment. It is a gross monthly amount, and the company said it will not be included in the calculation of Weinberg’s annual incentive payment.

No other terms of his employment were changed. Today the company's shares have moved 1.29% to a price of $11.76. For more information, read the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.